MedTech Dive1h
M&A and a separation take center stage in latest earnings season
BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...
Zimmer Biomet Holdings (ZBH) Receives a Buy from BTIG
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...
Cartilage Regeneration Market Set to Reach $5.62 Billion by 2034, Driven by Advancements in Regenerative Medicine and Minimally Invasive Procedures
The "Cartilage Regeneration Market by Type, by Treatment Modality, by Application Site, by Surgical Procedure, by End-user, ...
Zimmer Biomet price target lowered to $113 from $118 at Truist
Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.